everolimus,durvalumab,tremelimumab,5-fluorouracil
astrazeneca,novartis,pfizer
['duthy ', 'seqtor']
two studies presented at #esmo22 involving vhio suggest significant changes in the treatment of neuroendocrine tumours. the #duthy and #seqtor research is supported by , which is led by vhio's 
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre